Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis MariMed Ord Shs C.MRMD

Alternate Symbol(s):  MRMD

Healthcare
MariMed Inc. is a multi-state cannabis operator in the United States. The Company develops, owns, and manages seed to sale regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. Its products include whole flowers, pre-rolled flowers, vape cartridges, concentrates, and edibles. The Company’s Natures Heritage brand is a premium brand... see more

Opinion & Analysis (CSE:MRMD)

    The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

    Hannah Genig April 1, 2019